Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Caffeine (30mg) + Diphenhydramine (25mg) + Paracetamol (500mg) + Phenylephrine (5mg)
Therapeutic Category
Cold and Cough, General and OTC medicines, Pulmonary, Respiratory, Antihistamines, Antipyretics
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹65/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Paraplom D Tablet is a comprehensive solution designed to provide effective relief from the common symptoms of cold, flu, and allergies. This combination medication offers a blend of active ingredients that work together to alleviate multiple symptoms, such as congestion, headaches, body aches, and fever, making it a go-to remedy for those suffering from respiratory discomfort.
Together, these ingredients help to alleviate multiple symptoms at once, making Paraplom Cold Tablet a highly effective treatment option for those looking for fast relief from cold and flu symptoms. It is particularly useful for individuals who need to stay alert during the day while managing the discomfort caused by cold-related issues.
Side effects may include drowsiness, dizziness, dry mouth, nausea, increased heart rate, and in rare cases, difficulty sleeping.
Paraplom D Tablet is indicated for the symptomatic treatment of cold, flu, allergic rhinitis, nasal congestion, headache, fever, and other upper respiratory conditions.
Do not exceed the recommended dose. If symptoms persist or worsen, consult a healthcare professional. Avoid alcohol while using this medication.
in cool and dry place
Composition : Paracetamol (I.R.) 300mg + Paracetamol (S.R.) 700mg
Composition : Paracetamol (250mg/5ml)
Composition : Paracetamol (650mg)
Composition : Caffeine (30mg) + Diphenhydramine (25mg) + Paracetamol (500mg) + Phenylephrine (5mg)
Composition : Domperidone I.P. 10mg + Paracetamol I.P. 325mg
Composition : Paracetamol (100mg)
Composition : Paracetamol (1000mg) Infusion
Composition : Mefenamic Acid (100mg) + Paracetamol (250mg)
Composition : Mefenamic Acid (50mg) + Paracetamol (125mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination tablet is a multi-symptom cold and flu relief formulation used for the symptomatic treatment of common cold, fever, headache, body aches, nasal congestion, sinus discomfort, and allergy-related symptoms. Paracetamol helps reduce fever and relieve pain. Phenylephrine acts as a nasal decongestant to relieve blocked nose. Diphenhydramine helps reduce sneezing, runny nose, and other allergy symptoms. Caffeine helps counter drowsiness and enhances the effectiveness of pain relief. This combination is widely used in the ENT, respiratory, and general medicine segment.
Medical distributors and wholesalers can benefit from high seasonal and year-round demand, especially during cold, flu, allergy, and viral infection seasons. Multi-symptom cold medications are among the most frequently purchased products in pharmacies, ensuring strong retail turnover and repeat sales.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in ENT, respiratory, and general medicine segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high prescription frequency, strong OTC demand, and recurring seasonal sales, making it a fast-moving, high-volume, and stable pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in respiratory and general medicine formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the ENT and respiratory healthcare segment.